Positronium lifetime validation measurements using a long-axial field-of-view positron emission tomography scanner.

Autor: Steinberger WM; Siemens Medical Solutions USA, Inc., Knoxville, TN, 37932, USA. william.steinberger@siemens-healthineers.com., Mercolli L; Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Breuer J; Siemens Healthineers AG, Forchheim, Germany., Sari H; Siemens Healthineers International AG, Zurich, Switzerland., Parzych S; Center for Theranostics, Institute of Physics, Jagiellonian University, ul. Lojasiewicza 11, 30-348, Krakow, Poland., Niedzwiecki S; Center for Theranostics, Institute of Physics, Jagiellonian University, ul. Lojasiewicza 11, 30-348, Krakow, Poland., Lapkiewicz G; Center for Theranostics, Institute of Physics, Jagiellonian University, ul. Lojasiewicza 11, 30-348, Krakow, Poland., Moskal P; Center for Theranostics, Institute of Physics, Jagiellonian University, ul. Lojasiewicza 11, 30-348, Krakow, Poland., Stepien E; Center for Theranostics, Institute of Physics, Jagiellonian University, ul. Lojasiewicza 11, 30-348, Krakow, Poland., Rominger A; Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Shi K; Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Conti M; Siemens Medical Solutions USA, Inc., Knoxville, TN, 37932, USA.
Jazyk: angličtina
Zdroj: EJNMMI physics [EJNMMI Phys] 2024 Aug 30; Vol. 11 (1), pp. 76. Date of Electronic Publication: 2024 Aug 30.
DOI: 10.1186/s40658-024-00678-4
Abstrakt: Background: Positron emission tomography (PET) traditionally uses coincident annihilation photons emitted from a positron interacting with an electron to localize cancer within the body. The formation of positronium (Ps), a bonded electron-positron pair, has not been utilized in clinical applications of PET due to the need to detect either the emission of a prompt gamma ray or the decay of higher-order coincident events. Assessment of the lifetime of the formed Ps, however, can potentially yield additional diagnostic information of the surrounding tissue because Ps properties vary due to void size and molecular composition. To assess the feasibility of measuring Ps lifetimes with a PET scanner, experiments were performed in a Biograph Vision Quadra (Siemens Healthineers). Quadra is a long-axial field-of-view (LA-FOV) PET scanner capable of producing list-mode data from single interaction events.
Results: Ortho-Ps (o-Ps) lifetimes were measured for quartz-glass and polycarbonate samples using a 22 Na positron source. Results produced o-Ps lifetimes of 1.538 ± 0.036 ns for the quartz glass and 1.927 ± 0.042 ns for the polycarbonate. Both o-Ps lifetimes were determined using a double-exponential fit to the time-difference distribution between the emission of a prompt gamma ray and the annihilation of the correlated positron. The measured values match within a single standard deviation of previously published results. The quartz-glass samples were additional measured with 82 Rb , 68 Ga and 124 I to validate the lifetime using clinically available sources. A double-exponential fit was initially chosen as a similar methodology to previously published works, however, an exponentially-modified Gaussian distribution fit to each lifetime more-accurately models the data. A Bayesian method was used to estimate the variables of the fit and o-Ps lifetime results are reported using this methodology for the three clinical isotopes: 1.59 ± 0.03 ns for 82 Rb , 1.58 ± 0.07 ns for 68 Ga and 1.62 ± 0.01 ns for 124 I . The impact of scatter and attenuation on the o-Ps lifetime was also assessed by analyzing a water-filled uniform cylinder (20 ϕ × 30 cm 3 ) with an added 82 Rb solution. Lifetimes were extracted for various regions of the cylinder and while there is a shape difference in the lifetime due to scatter, the extracted o-Ps lifetime of the water, 1.815 ± 0.013 ns, agrees with previously published results.
Conclusion: Overall, the methodology presented in this manuscript demonstrates the repeatability of Ps lifetime measurements with clinically available isotopes in a commercially-available LA-FOV PET scanner. This validation work lays the foundation for future in-vivo patient scans with Quadra.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje